Mandate

Vinge advises Capillar in connection with Sweden’s first ever de-SPAC

Capillar and the minority shareholders have entered into an agreement to sell all shares in Spolargruppen Sverige AB, a Swedish leading player in pipe lining (so-called relining) and pipe flushing, to tbd30 AB (publ), a so called SPAC (Special Purpose Acquisition Company).

In connection with the proposed transaction, a process is initiated (so-called “de-SPAC” or company combination) which includes, among other things, that Nasdaq Stockholm AB examines the intended acquisition, application for listing and change of trading venue to Nasdaq First North Growth Market within the framework of Nasdaq Stockholm's regulations regarding SPACs.

As part of the continued financing, a number of institutional and other investors, including Lannebo Fonder and Carnegie Fonder, have undertaken to subscribe for 1,500,000 new class A shares in tbd30 in a directed new share issue at SEK 100 per share.

Vinges team primarily consists of Christina Kokko, Joacim Rydergård, Hannah Kajlinger and Philip Moré (M&A), Linnéa Sellström (Equity Capital Markets) as well as Matthias Schömer and Henrik Wastenson (Tax).

Related

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026